These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26795471)

  • 21. Multiple roles for keratin intermediate filaments in the regulation of epithelial barrier function and apico-basal polarity.
    Salas PJ; Forteza R; Mashukova A
    Tissue Barriers; 2016; 4(3):e1178368. PubMed ID: 27583190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "IF-pathies": a broad spectrum of intermediate filament-associated diseases.
    Omary MB
    J Clin Invest; 2009 Jul; 119(7):1756-62. PubMed ID: 19587450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Throughput Screening for Drugs that Modulate Intermediate Filament Proteins.
    Sun J; Groppi VE; Gui H; Chen L; Xie Q; Liu L; Omary MB
    Methods Enzymol; 2016; 568():163-85. PubMed ID: 26795471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregation.
    Sun J; Li P; Gui H; Rittié L; Lombard DB; Rietscher K; Magin TM; Xie Q; Liu L; Omary MB
    JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37485877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermediate filament proteins of digestive organs: physiology and pathophysiology.
    Omary MB
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G628-G634. PubMed ID: 28360031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assays to Study Consequences of Cytoplasmic Intermediate Filament Mutations: The Case of Epidermal Keratins.
    Tan TS; Ng YZ; Badowski C; Dang T; Common JE; Lacina L; Szeverényi I; Lane EB
    Methods Enzymol; 2016; 568():219-53. PubMed ID: 26795473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate filaments and stress.
    Pekny M; Lane EB
    Exp Cell Res; 2007 Jun; 313(10):2244-54. PubMed ID: 17524394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury.
    Usachov V; Urban TJ; Fontana RJ; Gross A; Iyer S; Omary MB; Strnad P;
    BMC Med; 2015 Aug; 13():196. PubMed ID: 26286715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Invasive Intravital Imaging of siRNA-Mediated Mutant Keratin Gene Repression in Skin.
    Hickerson RP; Speaker TJ; Lara MF; González-González E; Flores MA; Contag CH; Kaspar RL
    Mol Imaging Biol; 2016 Feb; 18(1):34-42. PubMed ID: 26169581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding.
    Kwan R; Chen L; Looi K; Tao GZ; Weerasinghe SV; Snider NT; Conti MA; Adelstein RS; Xie Q; Omary MB
    Hepatology; 2015 Dec; 62(6):1858-69. PubMed ID: 26126491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear membrane diversity: underlying tissue-specific pathologies in disease?
    Worman HJ; Schirmer EC
    Curr Opin Cell Biol; 2015 Jun; 34():101-12. PubMed ID: 26115475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamins at the crossroads of mechanosignaling.
    Osmanagic-Myers S; Dechat T; Foisner R
    Genes Dev; 2015 Feb; 29(3):225-37. PubMed ID: 25644599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.
    Rohena CC; Mooberry SL
    Nat Prod Rep; 2014 Mar; 31(3):335-55. PubMed ID: 24481420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity in the properties of NEFL mutants causing Charcot-Marie-Tooth disease results in differential effects on neurofilament assembly and susceptibility to intervention by the chaperone-inducer, celastrol.
    Gentil BJ; Mushynski WE; Durham HD
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1499-508. PubMed ID: 23618875
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.